Byline: Roger Anderson

Michael Ison, MD, associate professor in Medicine-Infectious Diseases and Surgery-Organ Transplantation, is co-chair of a group of scientists responsible for drafting the next edition of influenza treatment guidelines.

A group of scientists from Germany, Korea and the United States has shown how a member of the sirtuin gene family acts as a tumor suppressor to protect genome integrity.

Published in the Journal of Clinical Investigation, new research by Elizabeth Eklund, MD, points toward an alternative approach to treating the inherited and devastating bone marrow condition Fanconi anemia.

With the support of a five-year, $9 million NIH grant, Konrad Kording, PhD, is leading a team of scientists in exploring a new way to map the brain.

Navdeep Chandel, PhD, was able to induce cancer cell death by diminishing antioxidant protein activity, leading to an intolerable level of intracellular hydrogen peroxide.

Students, fellows, faculty and guests took part in a mini-symposium that featured two panels discussions, a scientific poster session and networking reception as part of the medical school’s World AIDS Day commemoration.

Although the mechanisms by which interferons, or signaling proteins, generate anti-cancer responses remain to be defined, Leonidas Platanias, MD, PhD, has revealed the essential role that certain enzymes play.

Kathryn Radigan, MD, has received an Early Career Investigator Award from the American Thoracic Society Foundation to study the link between leptin, a hormone that regulates appetite and obesity, and an increased susceptibility to influenza A-induced lung injury.